Drug intelligence / Profile preview

[68Ga]Ga-HKG301

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[68Ga]Ga-HKG301 is a diagnostic radiopharmaceutical consisting of the fibroblast activation protein (FAP)-targeting ligand HKG301 labeled with the positron-emitting isotope gallium-68. It is designed for use in positron emission tomography (PET) imaging to detect and characterize solid tumors, specifically by targeting FAP expressed on cancer-associated fibroblasts (CAFs) in the tumor stroma. Developed by Odense University Hospital, it is currently being evaluated in the FAPILOUS clinical trial for the staging and restaging of primary breast cancer, where it is compared against standard [18F]FDG PET/CT imaging. The tracer aims to provide high-contrast imaging of FAP-positive lesions, which are prevalent in breast cancer and other stroma-rich malignancies.

Other names
68Ga-HKG301Ga-68 HKG301Ga68 HKG301Ga 68 HKG301
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on [68Ga]Ga-HKG301.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]Ga-HKG301.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call